GT Biopharma Inc (GTBP)

$0.44 0.00 (0.00%)

15:57 EST GTBP Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 22.05M

PE Ratio -

EPS -

Volume (Avg. Vol.) 202,500

Day's Range 0.42 - 0.46

52-Week Range 0.08 - 0.77

Dividend & Yield N/A (N/A)

GTBP Stock Predictions, Articles, and GT Biopharma Inc News

From InvestorPlace
From the Web

7 Biotech Penny Stocks Worth a Gamble

By Josh Enomoto, InvestorPlace Contributor Nov 11, 2020

With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved.

GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes

By William White, InvestorPlace Writer Mar 10, 2020

GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher.

GT Biopharma Announces GTB-3550 TriKE(TM) Reduces Bone Marrow Blast Levels, Improves NK Cell Function and Proliferation, and No Toxicities Observed in AML and MDS Patients

From GT Biopharma, Inc. Dec 8, 2020

GTB-3550 Interim Results Presented at 62nd American Society of Hematology Annual Meeting and Exposition BEVERLY HILLS, CA / ACCESSWIRE / December 8, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform is pleased to announce the presentation of interim results for the Company's lead therapeutic

5 Penny Stocks To Watch Before Next Week; 3 Up Big In November 2020

From PennyStocks.com Nov 20, 2020

Are These Top Penny Stocks On your Watch List?

GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors

From PennyStocks.com Nov 19, 2020

BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma,…

GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors

From GT Biopharma, Inc. Nov 19, 2020

BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology is pleased to announce Dr. Greg Berk, M.D. has joined the Company's Board of Directors. Dr. Greg Berk is an Independent Director of the Company. Dr. Berk is a senior oncology drug development consultant. Dr.

Does Your List Of Penny Stocks Have These 4 Biotech Names On It?

From PennyStocks.com Nov 19, 2020

4 Penny Stocks Under $2.50 To Watch Right Now If You Like Biotech

GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer

From PennyStocks.com Nov 18, 2020

BEVERLY HILLS, CA / ACCESSWIRE / November 18, 2020 / GT Biopharma,…